The retinoblastoma protein (Rb) needs to be phosphorylated by cyclin-dependent kinases (CDKs) before mammalian cells can enter the S phase of the cell cycle. As protein phosphatase 1 (PP1) activates Rb and is itself a target for inhibitory phosphorylation by CDKs in vitro, we asked whether any effects of PP1 on cell cycle progression depend on its phosphorylation and are mediated through Rb.
Background
The two major events of the eukaryotic cell cycle, DNA replication (S phase) and cell division (M phase), are separated by two gap phases, G1 and G2. During these gap phases, a cell decides whether to proliferate, to withdraw from the cell cycle, or to die; these decisions are made at so-called checkpoints and attune a cell's responses to extracellular signals to its developmental status and/or the demands of cellular homeostasis. Although these checkpoints are poorly understood at the molecular level, it is believed that both unrestrained growth and the multiple genetic aberrations associated with malignant tumors are due to loss or damage of the pathways that converge on checkpoint controls [1] [2] [3] [4] .
In all eukaryotic cells, cell cycle progression is driven by multiple phosphorylations of key regulatory proteins [5, 6] , catalyzed by a family of Ser/Thr-specific protein kinases termed cyclin-dependent kinases (CDKs; for recent reviews, see [7] [8] [9] ). CDKs are transiently activated by complexing to cyclins and by a series of phosphorylation and dephosphorylation reactions; different cyclin-CDK complexes promote distinct phases of the cell cycle.
Understanding the regulation of how protein phosphatases oppose the action of CDKs is important to fully appreciate cell cycle control. The importance of phosphatase regulation has a static and a dynamic aspect: first, at any one time, the phosphorylation state of a given protein depends on the ratio of protein kinase and phosphatase activities; second, at times, dephosphorylation of CDK substrates may be necessary to ensure an orderly cell cycle, whereas at other times, dephosphorylation may allow for (temporary) halts.
Mammalian Ser/Thr-specific protein phosphatases (PPs; for recent reviews, see [10, 11] ) are represented by four distinct prototypes, PP1, PP2A, PP2B and PP2C [12] . The idea that phosphatases may be involved in growth control was generated when it was realized that a marine toxin, okadaic acid, is a powerful tumor promoter [13] and a specific inhibitor of PP1 and PP2A [14] . These discoveries have led to the suggestion that PP1 and PP2A might function as tumor suppressors in mammalian cells [15, 16] . Subsequent studies have indeed established roles for both PP1 and PP2A in cell growth regulation. Thus, genetic analysis of Aspergillus nidulans and Schizosaccharomyces pombe mutants has revealed that PP1 controls the completion of, or exit from, mitosis [17] [18] [19] [20] , whereas PP2A may inhibit entry into mitosis [20] . These genetic data were biochemically confirmed for vertebrate cells: microinjection of PP1-neutralizing antibodies into early mitotic cells arrests them in metaphase [21] .
Meanwhile, a variety of approaches has shown that PP2A negatively regulates the mitosis-specific form of CDK1 [22] [23] [24] , most likely by inactivating the tyrosine phosphatase Cdc25, an enzyme that participates in the activation of CDK1 [25, 26] . Also, SV40 small tumor antigen appears to induce cell proliferation by inhibiting PP2A [27] . Equally interesting is the observation that PP2A can be inactivated by a number of oncogenic protein tyrosine kinases in vitro [28] and in vivo, suggesting another pathway to transformation [29] . Most importantly, PP1 was identified as the most likely phosphatase to be responsible for the activation of the retinoblastoma tumor suppressor protein, Rb [30] [31] [32] [33] . Rb is heavily phosphorylated, and thus inactivated, by CDKs in late G1, thereby permitting cells to proceed into S phase (reviewed in [34] [35] [36] ). In summary, there appears to be sufficient evidence supporting the hypothesis that PPs inhibit cell growth. As there is, in mammalian cells, an important checkpoint shortly before S phase (mediated by Rb, as described), one would expect that this postulated function of PPs is, at least partially, associated with the G1 phase of the cell cycle.
We have previously shown that CDKs phosphorylate and inhibit PP1 in vitro, and have mapped the site of phosphorylation of the rabbit PP1␣ catalytic subunit (which has an identical amino acid sequence to all other cloned mammalian PP1␣ subunits, including the human isoform) to Thr320 [37] . In addition, in human MG63 osteosarcoma cells, PP1 activity oscillates in a cell-cycle-dependent manner with peaks in G0/G1 (cytoplasmic and nuclear) and G2/M (nuclear only); at the G1-S boundary and in S phase, PP1 activity is suppressed to about 25% of the maximum [37] . The cell-cycle-dependent activity profile of PP1 is inversely related to the degree of Rb phosphorylation and the activity of some CDKs, especially those that associate with G1-specific cyclins and/or cyclin A. Thus, we speculated that at some point in G1 CDKs not only inactivate Rb, but also inactivate PP1, in order to ensure maximal phosphorylation of Rb [33] . A site equivalent to Thr320 is apparently phosphorylated in vivo by the S. pombe CDK, Cdc2 [38] . However, owing to the difficulties associated with trapping phosphatases in their phosphorylated form [39] , evidence for in vivo phosphorylation of Thr320 in mammalian cells is still lacking.
In order to examine the function of the PP1␣ catalytic subunit in the cell cycle, as well as the potential role of the postulated phosphorylation of PP1␣ by CDKs, we have introduced recombinant wild-type PP1␣ and mutant PP1␣ (PP1␣T320A), which contains an alanine in place of threonine at the CDK phosphorylation site at residue 320, into electropermeabilized cells. The phosphorylation-resistant mutant could arrest cells in late G1 and prevent Rb phosphorylation, yet wild-type PP1␣ was unable to arrest cell growth and, accordingly, failed to alter the phosphorylation of Rb that normally occurs in cells approaching S phase. As Rb-negative cells were not growth-inhibited by either wild-type or mutant phosphatase, we conclude that the ability of PP1␣ to arrest cell growth may indeed depend on its phosphorylation state, and is mediated, perhaps exclusively, by Rb. Furthermore, we will discuss evidence suggesting that PP1 may induce cell death independently of Rb.
Results

Intact PP1␣ can be electrotransferred into MG63 cells
As PP1 is not readily overexpressed in mammalian cells, we have adopted the electroporation technique [40] to introduce recombinant PP1 into cells and study the role(s) of PP1 in cell cycle progression. Increasing the voltage or capacitance of electroporation increases the incorporation of protein into cells, but decreases the cell viability, and the extent of these changes is dependent on the cell type [40] . Therefore, we determined the conditions representing the optimal compromise between these two parameters for MG63 cells, the same cell line that was used in our previous study [37] . As shown in Figure 1a , by varying the voltage and capacitance between 120 and 280 V and 25 and 500 F, respectively, uptake of exogenous bovine serum albumin (BSA) increased from zero to nearly 6 g per 2 × 10 5 cells, establishing that MG63 cells incorporate foreign protein in a predictable fashion. However, the viability of cells dropped below 70% at capacitance settings ≥ 250 F. Therefore, we defined optimal conditionsthose which had the highest protein uptake for a tolerable recovery of surviving cells -as a voltage setting of 280 V and a capacitance of 125 F.
Using these optimal conditions, we treated between 2 × 10 5 and 3.2 × 10 6 cells with a constant relative amount of PP1␣. Densitometric analysis of the band intensities showed that approximately 22% of the PP1␣ protein present in the electroporation buffer was recovered in whole cell lysates (Fig. 1b) . Next, we treated 1.6 × 10 6 cells with an increasing amount of PP1␣ (between 15 and 240 units per 10 6 cells), and measured the PP1 activity in cytosolic lysates one hour after electroporation. The amount of activity recovered in cytosolic lysates was proportional to the amount used for electroporation: it varied between 12.9% and 16% (14.8% on average) of the amount used (Fig. 1c) , thus being slightly lower than the fraction of protein recovered in whole cells. This suggests that more of the exogenous PP1␣ localized in the cytosol than in the nuclear or membrane compartments. In summary, the successful incorporation into cells of the active PP1␣ catalytic subunit indicated that electropermeabilization could be used to study regulatory functions of PP1.
BSA and inactive PP1␣ do not halt cell cycle progression
Because of the elevated PP1 activity associated with the G0/G1 phase [37] and the known interaction between Rb and PP1 [30] [31] [32] [33] , our aim was to determine the role of PP1␣ in the G1-S transition and whether this function might be mediated through phosphorylation at Thr320. As a first step, it was necessary to estimate the duration of the G1 phase and the time of entry into S phase of cells released from G0/G1. The cells were harvested at regular intervals over a period of 24 hours and the percentage of cells in different phases of the cell cycle was estimated by flow cytometric analysis of the DNA content (Fig. 2a) . From 16 to 18 hours after release from G0, between 51% and 67% of the cells originally in G0/G1 had exited from G1; 22 hours after release from G0/G1, 89% of the cells were found to be in S and G2/M phases. Moreover, at the end of the observation period, the cells had not yet gone through a division as the cell number had not increased in comparison to controls at time zero. This control experiment helped to design the experiments involving PP1␣: first, it determined the time frame during which a sizable portion of cells was still in G1 and thus was suitable for electroporation with PP1␣; second, it established the time after which most cells had exited from G1 -at this time point any effect on the G1-S transition would become most apparent. Thus, we took the median length of the G1 phase as 18 hours, arbitrarily subdivided it into three periods of 6 hours each, and designated them early, mid and late G1; 22 hours appeared to be suitable to analyze PP1 effects on cell cycle progression.
We examined whether electroporation of cells with either BSA or inactive PP1␣ affects cell cycle progression. PP1␣ was made inactive by boiling or long-term storage. To establish the starting conditions, sister cultures of identically treated cells were analyzed by flow cytometry at the beginning of the experimental treatment -3, 9 and 15 hours after release from G0 (Fig. 2b) . Cells, harvested by trypsinization, were then subjected to one of three different treatments and replated: control cells were just kept on ice (Fig. 2c) while experimental cells were electroporated with either BSA (Fig. 2d ) or inactive PP1␣ (Fig. 2e) . All cells were analyzed by flow cytometry 22 hours after release from G0. In the PP1␣-treated cells, the band intensity of PP1␣ on western blots was approximately 10 times higher than that of endogenous PP1␣ (Fig. 2f) . The relative inhibition of G1 exit by foreign protein was negligible:
Research Paper Cell cycle arrest by PP1 Berndt et al. 377 it was calculated to be ≤ 12.8% for BSA and ≤ 12.9% for inactive PP1␣. This demonstrates that the presence of inactive PP1␣ alone did not hinder cell cycle progression any more than electroporation per se or the presence of BSA. Therefore, in the experiments described below, BSA treatment was used as a reference.
PP1␣ activity delays cell cycle progression in G1
When MG63 cells were electroporated and analyzed in a way analogous to that described above, it became apparent that recombinant wild-type PP1␣ and PP1␣T320A had different effects on cell cycle progression. A representative experiment is shown in Figure 3a -d. When transferred into cells in early G1, both wild-type and mutant PP1␣ effectively inhibited progression into S phase: the proportion of cells in G1 remained virtually constant over a 19 hour period. When transferred into cells in mid G1, the ability of wild-type PP1␣ to inhibit progression into S phase decreased almost two-fold when compared with the effect in early G1. In late G1, wild-type PP1␣ was unable to prevent cells from entering S phase, as indicated by the fact that, 7 hours later, the G1 fraction was as low as in BSA-treated controls. In contrast, mutant PP1␣ continued to inhibit cell cycle progression in mid and late G1 with similar effectiveness: the ratio of G1 cells at 22 hours to G1 cells before electroporation remained virtually unchanged at all three time points. Figure 3e summarizes the results from three experiments and shows the calculated relative inhibition of G1 exit.
In order to verify the levels of phosphatase, we determined the activity ( Fig. 3f ) and protein amounts ( Fig. 3g ) in cell lysates after completing the treatment: for both species of PP1␣, the activity was between 11-fold and 16-fold higher than the endogenous levels, and the protein levels were similarly elevated. The PP1␣ and PP1␣T320A bands were analyzed densitometrically, and the ratios of PP1␣:BSA and PP1␣T320A:BSA were similar at the end of the 19, 13 and 7 hour treatment periods (data not shown), demonstrating that the incorporated phosphatase was stable for at least 19 hours. The results of these experiments strongly suggest that the delay in G1 progression was due to PP1 activity and not to the mere binding of PP1 to other cellular proteins, as PP1 without enzyme activity had no such effect. 
Mutant PP1␣ prevents the G1-S transition and Rb phosphorylation in late G1
It is well established that the dephosphorylated form of Rb is associated with the G0/G1 phase and that Rb phosphorylation is required to permit passage from G1 to S phase [34] [35] [36] . Moreover, evidence has accumulated to suggest that Rb is dephosphorylated by PP1 in vivo [30] [31] [32] [33] . To identify a possible mechanism of action for the PP1␣-induced cell cycle effects, we examined the phosphorylation state of Rb in cells electroporated with PP1␣. To that end, we synchronized MG63 cells in late G1 with mimosine [41] , removed the arresting drug and electroporated the cells with wild-type or mutant PP1␣. Six hours later, one half of the cells was harvested to assess the DNA content by flow cytometry (Fig. 4a) . The other half of the cells was labeled with [ 32 P]inorganic phosphate ( 32 P i ) for 2.5 hours, 3.5 hours after replating, and then harvested. Rb was immunoprecipitated, separated by gel electrophoresis and visualized by autoradiography (Fig.  4b) ; as before, PP1␣ band intensities in treated cells were significantly higher than the endogenous levels (Fig. 4c) . Control cells were 32 P-labeled or analyzed by flow cytometry before release from mimosine arrest.
At time zero, the cell population was almost exclusively in G1 (Fig. 4a, 0 h ), and the Rb protein was largely underphosphorylated (Fig. 4b, 0 h ). Six hours later, the majority of control cells had proceeded into S phase (Fig. 4a,   6 h + BSA); accordingly Rb was, as expected, heavily phosphorylated (Fig. 4b, 6 h + BSA). In response to wildtype PP1␣, cells advanced into S phase unperturbed (Fig.  4a, 6 h + PP1␣), and Rb was phosphorylated to a similar level as in control cells (Fig. 4b, 6 h + PP1␣). However, cells treated with PP1␣T320A remained mostly in G1 (Fig. 4a, 6 h + T320A), and phosphorylation of Rb apparently did not increase beyond the levels seen at the beginning of the experiment (Fig. 4b , compare 0 h to 6 h + T320A). This experiment, performed with a cell population that was synchronized in late G1, confirmed the earlier observation that PP1␣T320A, but not PP1␣, blocks the G1-S transition.
Constitutively active PP1 causes cell growth arrest and cell death
The remarkable stability of PP1␣ electroporated into cells, as well as the ability of the electropermeabilized cells to proceed normally through the cell cycle, indicated that it was feasible to explore potential effects of PP1 on cell proliferation by electrotransfer. The inhibition of Sphase entry by PP1␣T320A could represent either a mere lengthening of the G1 phase or a cell cycle arrest. To distinguish between these two possibilities, we carried out an experiment over a longer period of time: we introduced wild-type PP1␣ or the phosphorylation-resistant mutant PP1␣T320A into a growing, asynchronous cell population, replated the cells at 2 × 10 5 cells per 75 cm 2 
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the cell number, cell viability, level of PP1 activity, and amount of PP1␣ protein, every 24 hours for 4 days.
Phosphatase-treated cells did not display any obvious changes in morphology when compared to either untreated or BSA-treated cells; the vast majority of the cells appeared fully attached and flattened out, suggesting that these cells were predominantly in G1 (data not shown). As shown in Figure 5a , during the first two days, cells treated with wild-type PP1␣ increased in number by 1.2-fold and 1.4-fold, respectively; over the same period, control cells grew more rapidly -1.7-fold and 2.2-fold. However, during the third and fourth day after replating, the relative increase in cell number of cells treated with PP1␣ was very similar to that of controls. In contrast, cells treated with the mutant PP1␣T320A did not grow at all during the first three days, yet resumed to proliferate during the fourth day, at essentially the same rate (1.9-fold) as control cells (2.2-fold). Growth inhibition or lack of growth was also observed when cells were plated at 8 × 10 5 cells per 75 cm 2 (data not shown), indicating that the observed effects were independent of cell density. As in previously described experiments, the magnitude of the effects suggest that PP1␣ had been incorporated into the vast majority of cells.
Interestingly, cells treated with mutant PP1␣ appeared to die more frequently: immediately after electroporation, approximately 15% of the cells were positive for trypan blue in all four cell populations (Fig. 5b) . One day later, untreated controls and cells treated with BSA or wild-type PP1␣ had apparently recovered, while the PP1␣T320A mutant significantly increased both the number and proportion of dead cells (Fig. 5b) . The basis for this finding will have to be investigated further (see Discussion). Treatment with inactive PP1␣ protein had no effect on either proliferation or cell viability (data not shown).
As expected, the growth inhibition or arrest was associated with elevated PP1 activity in cytosolic lysates (Fig. 5c ) and higher protein amounts (Fig. 5d) for both wild-type and mutant PP1␣. Until day three, the activity and protein levels in cells treated with PP1␣T320A remained virtually constant (between 6-fold and 8-fold higher than in BSA controls), yet dropped significantly on day four. The activity measured in cells treated with wild-type PP1␣ was initially elevated to similar levels (7-fold increase over basal level) as those in mutant-treated cells, but decreased more rapidly than in these cells, and was virtually identical to the basal levels on the fourth day. For wild-type PP1␣, the loss of activity (expressed in units per 10 6 cells) over time occurred more rapidly than the decrease in protein that could be seen in western blots in which each lane contains lysates of equal numbers of cells (Fig. 5d ). These results demonstrate that both wild-type and mutant PP1␣ protein remained essentially stable for 48 to 72 hours. The endogenous activity levels measured in cells released from G0 (for example, those shown in Fig. 3f ) were noticeably lower than those measured in this experiment, in which asynchronous cells mostly in G1 were used. As the former cells were enriched in S or G2/M phase (see Fig. 3a ), this finding was in keeping with our previous observation that cytosolic PP1 activity is suppressed during S and G2/M phases [37] . In similar experiments with the leukemiaderived, p53-negative HL60 cell line, the two PP1␣ species also induced growth inhibition or arrest (data not shown).
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Figure 4
Constitutively active PP1␣ prevents the G1-S transition and phosphorylation of Rb in MG63 cells. Cells (2 × 10 6 ) that had been synchronized by mimosine blockade (see Materials and methods), were either used before lifting the G1 arrest (0 h) or washed extensively to remove the drug, and electroporated with 100 g BSA, 100 U wildtype PP1␣, or 100 U PP1␣T320A, replated (1 × 10 6 cells) in duplicate and harvested 6 h later (6 h + BSA, 6 h + PP1␣, and 6 h + T320A, respectively). (a) One set of samples was used for flow cytometry and (b) another was 32 In summary, our experiments indicate that PP1␣T320A could induce growth arrest in serum-depleted or growing cells; therefore, this effect did not depend on whether the cells had to pass through G0 and G1 or only G1 to enter S phase. Secondly, it is worth noting that the effects on cell growth were reversible: they no longer persisted as soon as the excess activity had dropped to a level approximately 4-fold above the endogenous activity in BSA-treated cells.
PP1␣-induced growth arrest, but not cell death, depends on functional Rb
To determine whether Rb is a major, if not the only, target capable of mediating the growth arrest induced by PP1␣, we examined whether PP1␣ affects the growth properties of Saos2 cells, which have widely been used to study the consequences of Rb loss (see [42, 43] for example). As Saos2 cells were found to traverse the cell cycle much more slowly than MG63 cells (data not shown), we chose different time points for analysis in the next two experiments. An experiment that was designed similarly to the one presented in Figure 4 demonstrates that an excess of either wild-type or mutant PP1␣ was unable to prevent the transition from G1 to S phase in Saos2 cells (Fig. 6a) . The fact that adding mimosine to a population of control cells could keep most of them in a G1 arrest (Fig. 6a, 18 h + mim) demonstrates that the lack of effect of PP1␣ was not due to a general failure of these cells to be arrested at this point. Following electroporation of growing, asynchronous cells with phosphatase, the relative growth rates were very similar to controls (except for day one, see below), indicating that neither form of PP1␣ could induce cell growth arrest in Saos2 cells (Fig. 6c) . As with MG63 cells, we observed increased numbers of trypan-blue positive cells following electroporation; whereas the BSA-treated control cells recovered from this damage during the first 2 days, both phosphatase-treated cell populations sustained massive cell death during the first 24 hours (Fig. 6d) . This, and not cell growth arrest, is the most likely explanation for the substantially decreased cell number of phosphatase-treated cells that persisted throughout the observation period (Fig. 6c) .
Discussion
Role of PP1␣ in the G1 phase of the cell cycle
In this study, we have examined potential role(s) of PP1␣ in cell growth control by introducing recombinant protein into human Rb-positive and Rb-negative osteosarcoma cells. The main results of this paper are as follows. In Rbpositive cells, elevated levels of PP1␣ negatively affected G1 progression and cell proliferation. At the same time, the effects of a mutant PP1␣ that lacks the CDK phosphorylation site Thr320 markedly differed from those of wild-type PP1␣. The Thr→Ala mutant cannot be inhibited by phosphorylation at this site [37] , whether by CDKs or any other protein kinase, and is therefore constitutively active. This mutant effectively prevented the 
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G1-S transition, thus causing cell growth arrest, whereas wild-type PP1␣ merely protracted the G1 phase leading to a lower growth rate. A molecular framework for these effects is provided by the observation that, shortly before S-phase entry, the PP1␣T320A mutant kept Rb in a dephosphorylated state, whereas wild-type PP1␣ did not prevent the Rb phosphorylation that normally occurs at this point. In Rb-negative cells, neither wild-type PP1␣ nor PP1␣T320A affected the G1-S transition or the proliferation rate of the cells, which suggests that the growthsuppressing potential of PP1␣ requires the presence of functional Rb. The same has been reported for the CDK inhibitor p16INK [43, 44] . Although we have observed nearly identical results in two different Rb-positive cell lines, further studies will be needed to determine whether PP1␣-induced cell cycle arrest functions universally in mammalian cells or is, perhaps, developmentally regulated.
The differential effects of wild-type and mutant PP1␣ support the hypothesis that phosphorylation at Thr320 of the protein plays a key role in the G1-S transition of the mammalian cell cycle. The enzyme activity in cells treated with wild-type PP1␣, however, was only slightly smaller than that in mutant-PP1␣-treated cells. This suggests that only a minor portion of PP1␣ is subject to phosphorylation at Thr320, which may not be surprising given that the PP1␣ enzyme system is believed to play multiple roles in cells [10, 11, 33] . Direct proof that PP1␣ is being phosphorylated in vivo in a cell-cycle-dependent manner was not obtainable at this time, as an antibody capable of immunoprecipitating the phosphorylated form of PP1␣ was not available to us.
Bearing in mind that cell cycle regulatory mechanisms are highly conserved throughout the eukaryotic world, regulation of PP1 by CDK phosphorylation in mammalian cells appears to be very likely because the S. pombe homolog of PP1, Dis2, is inhibited in vitro through phosphorylation at Thr316 (which corresponds to Thr320 in mammalian PP1␣) by Cdc2 [38] , and becomes phosphorylated at the onset of M phase [45] . Interestingly, overexpression of the mutant dis2T316A greatly inhibited cell division in S. pombe [38] . On the basis of these findings, it was suggested that PP1
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Figure 6
PP1␣ does not inhibit the G1-S transition or proliferation in Saos2 cells. As Saos2 cells were more susceptible to damage and took a longer time to re-attach when electroporated under the same conditions as MG63 cells, the voltage was reduced to 200 V, and the cells were replated in gelatin-coated flasks. Cells (2 × 10 6 ) were electroporated as before, except that the amount of PP1␣ used was increased to 300 U. 83.3% G1 4.1% G1 82.8% G1
6.1% G1 9.5% G1 5.3% G1 1n 2n 1n 2n 1n 2n DNA content inactivation may be necessary for entry into mitosis, whereas restoration of activity may be required for exit from mitosis [38] . Our findings suggest that, in mammalian cells, a somewhat similar mechanism may pertain to the transition from G1 to S phase. Given that S. pombe has a very short G1 phase and therefore grows in length in G2, whereas mammalian cells are thought to make the important decisions concerning proliferation in G0/G1 [1] [2] [3] [4] , a mechanism implicating PP1 in the control of entry into S phase may be useful for mammalian cells.
A possible connection between phosphatase activity, the phosphorylation state of Rb, the G1-S transition and/or cell growth regulation has been suggested by previous studies in different systems. That a phosphatase must be important in regulating Rb function could be inferred from the fact that only the dephosphorylated form of Rb has growth-suppressing activity [42, 46] . Furthermore, the growth arrest induced by transforming growth factor ␤1 is associated with a lack of Rb phosphorylation [47, 48] and rapid activation of PP1 [49] ; whether these observations are causally related is not clear, but became more plausible after several laboratories, including our own, identified PP1 as an Rb phosphatase [30] [31] [32] [33] . The lack of Rb phosphorylation that we saw in response to PP1␣T320A, was possibly due to two effects, either alone or in combination: direct dephosphorylation of Rb by the phosphatase, or interference with pathways that activate the Rb kinases CDK4/6 and/or CDK2. The ability of wildtype PP1␣ to delay G1 progression also depended on functional Rb. From our earlier observation that shortterm inhibition of PP1 promotes Rb phosphorylation in G0/G1, we speculated that PP1 activity is required to keep Rb in a dephosphorylated state [33] . These new results suggest that a gross imbalance in favor of the Rb phosphatase PP1 is sufficient to keep Rb locked in a dephosphorylated state. This may be due either to PP1 acting on Rb directly or to indirect effects, such as PP1␣ reducing CDK promoter activity [50] . Eventually, however, exogenous PP1 might not be able to escape its inactivation, thus explaining its failure to induce growth arrest.
Our results differ in one aspect from one of the studies identifying PP1 as an Rb phosphatase: microinjection of purified PP1 into rat REF-52 fibroblasts renders Rb resistant to extraction from the nucleus (which was interpreted as a sign of underphosphorylation), and inhibits DNA synthesis for a period of 6 hours [31] . In contrast to our results, these effects were only seen when the enzyme was injected just before S phase, but not earlier in G1. Possible reasons for the discrepancy between these findings and our own results are that, in REF-52 cells, the enzyme becomes phosphorylated earlier in G1 phase or, as the authors discussed, PP1 may be less stable in REF-52 cells than our data would suggest for MG63 cells.
Finally, our study may offer a new explanation for the difficulties encountered by laboratories trying to overexpress PP1 in mammalian cells. It has been assumed that this difficulty is mainly due to PP1 being grossly toxic to cells, to the failure of PP1 to fold correctly, and/or to the requirement for a second protein that can act as a molecular chaperone. Our results suggest that excess free PP1 catalytic subunit, when active, can play a pivotal role in mammalian cells. It was shown by Fernandez et al. [51] that microinjected PP1 leads to a transient disassembly of the actin microfilament network that last for up to 90 minutes. In our experiments, which spanned time periods of no less than 7 hours, we have not observed any gross effects of increased PP1␣ levels on cellular morphology or survival. Thus, no effects on the actin microfilament structure were seen when we stained treated MG63 cells with rhodamine-phalloidin every 24 hours (data not shown). In any case, future attempts to establish a functioning PP1 expression system may have to take into account the fact that PP1 is growth-suppressing. Therefore, successful expression of PP1 has probably to await a reliable, tightly regulated inducible promoter, because any expression during the selection period or longer-lasting contamination of PP1-expressing cells with non-transfected cells will make more difficult the generation of a PP1-expressing cell population that is sufficiently large for analysis.
The fact that the PP1␣-induced growth inhibition was reversible, even with the phosphorylation-resistant mutant, would further argue against a generalized toxic effect of PP1. In this context, it is important to note that PP1␣ and PP1␥1 were found to be overexpressed in a variety of human tumors, which was taken as evidence for a positive role of PP1 in tumorigenesis [52] [53] [54] . Our results suggest a different scenario: PP1 may be overexpressed in certain tumors to prevent a more rapid growth. Obviously, it will be important to determine how deletion of PP1 activity affects cell growth.
PP1␣ and cell death
In Rb-positive cells, the mutant PP1␣T320A appeared to activate Rb and cause cell cycle arrest and/or cell death. Although we have not yet carried out stringent assays establishing apoptosis, these results are in agreement with two recent reports that have addressed the possible involvement of PP1 in apoptosis by using different approaches. First, Dou et al. [55] showed that treatment of p53-negative HL-60 cells with the anti-cancer drug cytosine arabinoside induces Rb phosphatase activity, G1 arrest and eventually apoptosis. Although in that study no attempt had been made to identify the protein phosphatase in question, several studies have, as already pointed out, implicated PP1 in the dephosphorylation of Rb [30] [31] [32] [33] . Furthermore, on the basis of evidence obtained with phosphatase inhibitors, Morana et al. [56] have shown that PP1 can activate apoptosis. In the latter study, in several models of apoptosis examined, the Rb protein was also dephosphorylated and cells were in S phase when undergoing cell death; it was thus assumed that phosphorylation of Rb during S phase prevents apoptosis [56] . Our results are consistent with this plausible scenario.
The fact that PP1␣ could apparently induce cell death in Saos2 cells suggests that there may be another pathway to apoptosis that involves the dephosphorylation of one or several proteins other than Rb. Both wild-type PP1␣ and PP1␣T320A led to a similar increase in cell death, suggesting that another pool of PP1, not susceptible to CDK phosphorylation, is involved in this process, which again (see above) is consistent with the model of multiple roles for individual phosphatases.
Conclusions
To our knowledge, this study represents the first demonstration that a PP1 catalytic subunit has the potential to cause mammalian cell cycle arrest. This potential was apparently dependent on the induction of sustained dephosphorylation of functional Rb and on the presence of an Ala residue at position 320 of PP1␣ which eliminates a CDK phosphorylation site. These findings suggest that PP1␣ is being periodically inactivated through phosphorylation at Thr320, most probably by CDKs that regulate passage from mid/late G1 to S phase, thereby relieving a block preventing S-phase entry. Inactivation of PP1, either by phosphorylation and/or other mechanisms, may be required to permit entry of cells into S phase. Further experiments will be needed to address this hypothesis. In addition, we found that PP1␣ was able to induce cell death, regardless of the Rb status of cells. Although the exact mechanism underlying this latter finding remains to be determined, together, our results should be encouraging enough to prompt an exploration of whether activating the PP1 pathway may be exploited in tumor therapy.
Material and methods
Cells, chemicals and proteins
Human osteosarcoma cells (MG63 and Saos2) and leukemia cells (HL60) were obtained from the ATCC and grown in RPMI-1640 or DMEM cell culture medium, respectively (Irvine Scientific). Fetal bovine serum (FBS) was purchased from Gibco-BRL, phenylmethylsulfonyl fluoride (PMSF) from Pierce, ␥-[ 32 P]ATP and 32 P i from ICN, chromatography media, the E. coli expression vector pDR540 and Protein-A-Sepharose Fast Flow from Pharmacia, okadaic acid from LC Laboratories, and all other chemicals from Sigma unless otherwise stated. Wild-type PP1␣ and PP1␣T320A were expressed in E. coli and purified as previously described [37, 57] . The final preparations were stored at -20°C in 20 mM Tris/Cl pH 7.5, 0.1 mM EDTA, 0.1 mM EGTA, 0.1% (v/v) 2-mercaptoethanol, 50% (v/v) glycerol. Phosphorylase b and phosphorylase kinase were kindly provided by B.S. Khatra, California State University. Antipeptide antibodies specific for the ␣-isoform of PP1 (anti-C␣) were prepared as described [58] . Antibodies to the intact PP1 catalytic subunit (FL-18) and antibodies to human Rb (C-15) were obtained from Santa Cruz Biotechnology.
Electrotransfer of PP1 into cells
Subconfluent cells were washed twice with serum-free medium, trypsinized, collected in a 15 ml tube and centrifuged at low speed for 8 min. Cells were resuspended and washed twice in medium. An aliquot of the cell suspension was diluted 1:2 with 0.4% trypan blue and counted with a hemacytometer. Cells were only used for electroporation if the viability exceeded 95%. We optimized the electrotransfer of PP1 into MG63 cells following the guidelines described by Wilson et al. [40] . Typically, 1-2 × 10 6 cells were transferred to a electrocuvette with a 0.4 cm electrode gap and mixed with purified PP1 diluted in medium; the final volume was adjusted to 100-200 l; the control protein, BSA, was dissolved in the same buffer as PP1 [57] . This suspension was incubated for 10 min on ice. Using the gene pulser plus capacitance extender (Bio-Rad), the cells were subjected to a pulse of 280 V (MG63) or 200 V (Saos2 and HL60) at a capacitance of 125 F (MG63 and Saos2) or 250 F (HL60), and a resistance setting to ∞. Under these conditions, the time constant turned out to be between 15 and 45 msec. After the pulse, the cells were incubated for another 10 min on ice, and then slowly diluted with medium containing 10% FBS that was kept at 37°C. After measuring the viability of the electroporated cells, the cells were replated at a predetermined density and cultured for up to four days.
Cell synchronization and metabolic labeling with 32 P i
To obtain MG63 cells in G0, 1 × 10 6 cells were cultured in 75 cm 2 flasks in RPMI-1640 medium containing 0.5% FBS for 48 h [37, 59] . Medium containing 10% FBS was then added to the cells to stimulate re-entry into the cell cycle. To obtain MG63 or Saos2 cells arrested in late G1, serum-deprived cells were incubated for a further 24 h in the presence of 10% FBS and 600 M mimosine [41] . For metabolic labeling, cells were first incubated for 30 min with 2 ml phosphate-free medium containing 5% FBS that had been dialyzed against phosphatefree medium, and then labeled with 32 P i (1.2 mCi per 10 6 cells) for 2.5 h.
Flow cytometry
To monitor the cellular synchrony, at least 1 × 10 6 cells were harvested, washed with Hanks' balanced salt solution and fixed in 5 ml ice-cold 70% (v/v) ethanol. The cells were washed in phosphate-buffered saline (PBS) and incubated in the presence of 40 g ml -1 RNase A for 30 min at 37°C. After washing the cells with PBS, propidium iodide was added to a final concentration of 40 g ml -1 . The DNA profiles were examined with a FACScan flow cytometer using the program CellQuest (Becton-Dickinson) [60, 61] . To estimate the proportion of cells in G0/G1, S and G2/M phases, the histograms were analyzed with the ModFit program (Verity Software).
Preparation of cell lysates
After phosphate labeling, the radioactive medium was discarded and the cells washed three times with serum-free medium. The cells were lysed in the flask with 1.2 ml ice-cold RIPA buffer (50 mM Tris/Cl pH 7.5, 0.1 mM EDTA, 150 mM NaCl, 1% (v/v) NP-40, 0.1% (w/v) SDS) supplemented with freshly added protease, protein kinase and protein phosphatase inhibitors: 0.5 mM EDTA, 0.1 mM PMSF, 1 mM benzamidine, 1 g ml -1 pepstatin A, 0.5 g ml -1 leupeptin, 2 g ml -1 aprotinin, 100 mM NaF, 1 mM Na 3 VO 4 and 5 M okadaic acid.
In all other experiments, following treatment and incubation for various periods of time, the cells were trypsinized, washed in serum-free medium and collected by low-speed centrifugation for 8 min. An aliquot of the cellular suspension was diluted two-fold with 0.4% trypan blue and counted with the aid of a hemacytometer. Cellular suspensions were then divided into several aliquots for different analyses: first, to measure enzyme activity, cells were lysed with buffer A (50 mM Tris/Cl pH 7.5, 150 mM NaCl, 1% (v/v) NP-40, 0.1 mM EDTA, 0.1 mM EGTA) plus freshly added protease inhibitors and 0.1% (v/v) 2-mercaptoethanol; second, for western blots of PP1␣, cells were lysed with RIPA buffer; and third, for straight electrophoretic analyses, cells were lysed with boiling 2× concentrated SDS sample buffer (0.125 M Tris/Cl pH 6.8, 4% SDS, 20% glycerol, 10% (v/v) 2-mercaptoethanol, 0.05% bromophenol blue). The DNA was sheared by passing the sample repeatedly through a 21-gauge needle. All lysates were cleared by high speed centrifugation (3 min at 16 000 g).
Protein phosphatase assays
PP1 activity was determined according to standard procedures [62] [63] [64] as previously described [37] . Diluted samples containing PP1 were incubated in the presence of 10.2 M [ 32 P]phosphorylase a (1 mg ml -1 ) and 2 nM okadaic acid to selectively inhibit PP2A. One unit (U) of activity is defined as the amount that catalyzes the release of 1 nmol P i from phosphorylase a per min at 30°C.
Immunoprecipitation of Rb from 32 P-labeled cells
Cell lysates were pre-cleared by adding 1 g of anti-rabbit IgG and 30 l of protein-A-Sepharose (containing 1 vol beads and 1 vol RIPA buffer), followed by incubation for 30 min on ice. The beads were collected by centrifugation for 4 min at 1500 g at 4°C. The supernatants containing up to 2 × 10 6 lysed cells were incubated with 1.5 g antiRb antibody for 90 min on ice. Then 30 l protein-A-Sepharose was added to the lysates and incubated for 2 h with slow end-over-end rotation at 4°C. The beads were centrifuged for 4 min at 1500 g at 4°C. After aspiration of the supernatant with a 25-gauge needle, the beads were resuspended in a modified RIPA buffer (50 mM Tris/Cl pH 7.5, 0.1 mM EDTA, 0.1 mM EGTA, 100 mM NaCl, 1% (v/v) NP-40, 0.1% (w/v) SDS) containing freshly added protease inhibitors. The beads were centrifuged as before and washed three more times. The beads containing the immune complexes were then mixed with 40 l of 2× concentrated SDS sample buffer and boiled for 5 min.
Gel electrophoresis and western blotting
Whole cell lysates or immunoprecipitated protein were analyzed by SDS-polyacrylamide gel electrophoresis [65] on pre-cast tris-glycine gels from Novex and, if necessary, electrotransferred to Immobilon-P membranes (Millipore) [66] . Samples in adjacent lanes corresponded to either equal number of cells or, in the case of 32 P-labeled cells, equal amounts of protein. Membranes were probed for 2 h with anti-C␣ (1 g ml -1 ) [67] and then incubated for 1 h with 50 ng ml -1 anti-rabbit IgG conjugated to horseradish peroxidase (Kirkegaard & Perry Laboratories). Immunoreactive proteins were visualized with the ECL system from Amersham according to the manufacturer's instructions.
Note added in proof
After revision of this manuscript, a paper by Kwon et al. (Proc Natl Acad Sci USA 94:2168-2173) reported mitotic phosphorylation of mammalian PP1␣ at Thr320. Recent experiments in our laboratory suggest that Thr320 of PP1␣ is phosphorylated at two points during the cell cycle: first, from late G1 through to early S phase (as postulated in this study); and second, from G2 through to early M phase.
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